In a European work-sharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
Key takeaways of Q3FY22 quarter & conference call highlights
The start-up has announced the scheme to mark World Diabetes Day
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
A total of 12 generic medicines have been included in the list
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
Subscribe To Our Newsletter & Stay Updated
